Skip to main content

Want a detailed portfolio tracker?

Sionna Therapeutics (SION) P/E (2025 - 2026)

Sionna Therapeutics (SION) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Sionna Therapeutics (SION) P/E is -24.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sionna Therapeutics (SION)

YearP/EChange
2026-24.63+1.56%
2025-24.25N/A

Comparison Sionna Therapeutics (SION) P/E with competitors

Sionna Therapeutics (SION) P/E is -24.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.30%
FGENFibroGen Inc0.24-100.97%
CHRSCoherus Biosciences Inc0.85-103.44%
FBIOFortress Biotech Inc0.95-103.85%
ORMPOramed Pharmaceuticals Inc1.50-106.10%
AGENAgenus Inc3.01-112.22%
INVAInnoviva Inc3.15-112.80%
VXRTVaxart Inc3.55-114.41%
CRMDCorMedix Inc3.63-114.73%
CVACCureVac N.V.4.45-118.05%
GLPGGalapagos NV4.86-119.73%
SRPTSarepta Therapeutics Inc4.88-119.82%
ABEOAbeona Therapeutics Inc5.39-121.87%
ABUSArbutus Biopharma Corp5.60-122.72%
ZVRAZevra Therapeutics Inc5.89-123.90%
SPROSpero Therapeutics Inc6.23-125.29%
CGENCompugen Ltd6.31-125.63%
RIGLRigel Pharmaceuticals6.87-127.90%
SLXNSilexion Therapeutics Corp7.30-129.62%
OMEROmeros Corporation9.26-137.59%
AUPHAurinia Pharmaceuticals Inc9.58-138.91%
PLXProtalix BioTherapeutics Inc10.89-144.22%
ACADAcadia Pharmaceuticals Inc11.73-147.62%
TBPHTheravance Biopharma Inc12.26-149.78%
ADMAAdma Biologics Inc12.42-150.42%
HRMYHarmony Biosciences Holdings Inc13.82-156.11%
SABSSAB Biotherapeutics Inc14.14-157.39%
NAGENiagen Bioscience Inc14.82-160.16%
INCYIncyte Corp15.82-164.24%
REGNRegeneron Pharmaceuticals Inc15.86-164.37%
PBYIPuma Biotechnology Inc17.32-170.30%
CPRXCatalyst Pharmaceuticals Inc17.44-170.80%
EXELExelixis Inc17.54-171.20%
TGTXTG Therapeutics Inc18.97-177.00%
MDXGMimedx Group Inc20.55-183.44%
XOMAXOMA Royalty Corp22.87-192.87%
ARGXArgen X SE24.30-198.65%
CTMXCytomX Therapeutics Inc24.82-200.77%
XOMAOXOMA Royalty Corp25.34-202.90%
HALOHalozyme Therapeutics Inc25.62-204.03%
XOMAPXOMA Royalty Corp25.67-204.22%
VRTXVertex Pharmaceuticals Inc27.99-213.66%
RPRXRoyalty Pharma plc - Class A28.69-216.47%
SLNOSoleno Therapeutics Inc29.02-217.80%
ASNDAscendis Pharma A/S30.09-222.14%
LGNDLigand Pharmaceuticals Inc - Class B37.91-253.92%
APLSApellis Pharmaceuticals Inc39.02-258.42%
BMRNBiomarin Pharmaceutical Inc42.21-271.38%
KRYSKrystal Biotech Inc45.34-284.09%
ONCBeiGene Ltd69.54-382.33%
PHARPharming Group N.V.75.03-404.60%
TECHBio-Techne Corp101.96-513.94%
VCELVericel Corp109.92-546.27%
ALNYAlnylam Pharmaceuticals Inc117.96-578.93%
GMABGenmab140.29-669.57%
TLXTelix Pharmaceuticals Ltd162.15-758.33%
CORTCorcept Therapeutics Inc212.86-964.18%